Posts

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved a new PCORI Funding Announcement (PFA) that makes up to $40 million available for comparative clinical effectiveness research (CER) on treatment options for pediatric anxiety disorders.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $57 million to fund 14 new comparative clinical effectiveness research (CER) studies.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $9 million to fund a new study comparing two approaches to relieving noncancer chronic pain and reducing opioid use.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded nearly $2.4 million for 50 new projects through its Pipeline to Proposal Awards program, which is designed to develop a nationwide community of patients, researchers and other healthcare stakeholders with the knowledge and capacity to participate in patient-centered outcomes research (PCOR).

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $8.6 million to fund a new study comparing treatment options for people with psoriasis. The Board also approved $2.75 million to support a $5 million funding opportunity in partnership with the American Heart Association (AHA) to improve the treatment of atrial fibrillation (AFib).

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved about $18 million to fund two studies comparing different ways to manage the transition of people with sickle cell disease from pediatric to adult care.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved about $38 million to fund five studies comparing the effectiveness of different strategies for treating multiple sclerosis (MS).

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $97.9 million to fund 11 studies comparing different approaches to improving care for a range of health conditions that impose high burdens on patients, caregivers and the healthcare system.

PCORI Executive Director Joe Selby, MD, MPH, issued the following statement about the recent death of PCORI Board of Governors member Robert Jesse, MD, PhD.

The Patient-Centered Outcomes Research Institute's (PCORI) Board of Governors today approved more than $115 million to fund 20 comparative clinical effectiveness research (CER) studies on a range of conditions that impose high burdens on patients, their families and the healthcare system.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved the selection or reappointment of 33 people to serve on PCORI’s seven multi-stakeholder advisory panels.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved just under $10 million to fund two studies comparing the effectiveness of strategies designed to reduce unsafe opioid prescribing by improving pain management.

The Patient-Centered Outcomes Research Institute’s (PCORI) Board of Governors today approved nearly $74 million to fund seven studies comparing the effectiveness of different strategies for delivering palliative care.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded more than $3 million for 83 new projects through its Pipeline to Proposal Awards program. This initiative is designed to develop a nationwide community of patients, researchers and other healthcare stakeholders with the knowledge and capacity to participate in patient-centered outcomes research (PCOR).

The Patient-Centered Outcomes Research Institute (PCORI) today announced a new initiative designed to help patients work with their clinicians to choose the healthcare options best suited to their needs.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved the development of two new PCORI Funding Announcements (PFAs) that together will offer up to $41 million in support of comparative clinical effectiveness research (CER).

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today adopted the newest version of the PCORI Methodology Standards. The updates include new standards on analysis of clustered data, inclusion of a formal study protocol in public data, and approaches to selection and usage of data networks, among other changes.

Rachael Fleurence, PhD, PCORI’s Program Director for Research Infrastructure, has accepted an invitation to serve as the first Executive Director for the new National Evaluation System for Health Technology (NEST) Coordinating Center.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $34 million to fund three large comparative clinical effectiveness research (CER) studies and research to enhance the methods for conducting CER. The funds will support studies of a range of conditions and problems that impose high burdens on patients, caregivers and the healthcare system.

The Patient-Centered Outcomes Research Institute (PCORI) has issued nine new announcements offering up to a total of $200 million in funding for studies comparing which different healthcare options work most effectively for which patients across a range of conditions.

The Patient-Centered Outcomes Research Institute (PCORI) today named Kristin Carman, MA, PhD, as its new Director of Public and Patient Engagement.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $42 million to fund 19 new studies comparing which healthcare approaches work best.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today authorized making up to $50 million available for studies comparing non-surgical interventions for the treatment of chronic low back pain through a new PCORI Funding Announcement (PFA).

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $14.8 million to fund a study of two newer blood-thinning medications. The study will compare the two drugs against each other and against the older drug warfarin to see which works best in preventing the recurrence of dangerous blood clots in the veins and lungs.

The Patient-Centered Outcomes Research Institute (PCORI) this week welcomes two new Board of Governors members—Russell Howerton, MD, Chief Medical Officer and Vice President of Clinical Operations at Wake Forest Baptist Medical Center, and Kathleen Troeger, MPH, Director of Outcomes Research at Hologic, Inc.